Skip to content

Radiology Rewired | Conversations that move radiology forward
Hosted by Vivek Singh, MD

Tune in
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
featured-image

Stroke

Radiology Rewired: redefining stroke care through innovation and AI

Radiology is being reshaped by tools that amplify clinical judgment, not compete with it. Few people embody that evolution more than Dr. Greg Albers, co-founder of RapidAI and professor of neurology at Stanford University. Long before AI became part of everyday clinical practice, his research team was using early automated imaging software in landmark trials to quantify tissue viability and identify which patients still had something to save. As he explains, “Imaging could show us who was likely to benefit from treatment, and software gave us a way to measure that accurately and quickly.”
featured-image

AI

Radiology’s real challenge isn’t speed, it’s cognitive burden

The reality of cognitive burden, in radiologists’ own words Radiologists often describe cognitive burden not as the difficulty of interpretation itself, but as the accumulation of mental strain throughout the day. One radiologist captured it simply:
featured-image

Physician

Scaling AI from siloed tools to an enterprise platform

Artificial intelligence (AI) has the power to transform healthcare—but only if it can be scaled across the enterprise. In many systems today, AI exists in silos: one algorithm in radiology, another in the ED, and a third in population health. The result? Fragmented workflows, inconsistent ROI, and missed opportunities to improve patient care. To move from isolated tools to a true enterprise platform, healthcare leaders must take a strategic, integrated approach to scaling AI.
featured-image

Stroke

The Impact of Automated Software on Alberta Stroke Program Early CT Score

The Alberta Stroke Program Early CT Score (ASPECTS) is essential for clinical decision-making when treating ischemic stroke patients. It helps measure early ischemic changes and predict the functional outcome of endovascular thrombectomy.
featured-image

Aneurysm

Funding brain aneurysm research: Q&A with Christine Buckley of the Brain Aneurysm Foundation

RapidAI is proud to partner with the Brain Aneurysm Foundation (BAF) and support its mission to promote early detection of brain aneurysms by raising awareness of the signs, symptoms, and risk factors.
featured-image

Stroke

Neurovascular imaging for patients with suspected transient ischemic attack

Approximately 240,000 people in the United States experience a transient ischemic attack (TIA) annually. A TIA is a stroke lasting only a few minutes when the blood supply to part of the brain is briefly interrupted.
featured-image

Stroke

Mastering the Art of Patient Transfer: Utilizing RapidAI Software for Seamlessly Transferring Patients to a Different Hospital

Neuroimaging has played a significant role in the stroke workflow following the DAWN and DEFUSE 3 trials and revised guidelines for acute ischemic stroke treatment. It helps determine which patients are eligible for endovascular thrombectomy (EVT) in the late window.
featured-image

Stroke

Optimal patient selection for endovascular thrombectomy procedure: CT Perfusion versus Non-contrast CT

Landmark stroke clinical trials DAWN and DEFUSE 3 helped validate the benefits of endovascular thrombectomy (EVT) procedure in acute ischemic stroke patients (AIS) in the late window. CT perfusion (CTP) aided in selecting eligible patients with a favorable perfusion profile.
featured-image

Stroke

Neuroprotectant ApTOLL reduced death and disability in acute ischemic stroke patients

ApTOLL, a neuroprotective agent, has shown promising results in the APRIL 1b/2a trial and reduced death and disability when used alongside standard treatment in selected ischemic stroke patients. Rapid CTP helped with patient selection and mismatch determination.
1 2